Hangzhou AGS Medtech Co (SHSE:688581) Net Income From Continuing Operations : ¥235.8 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Hangzhou AGS Medtech Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Hangzhou AGS Medtech Co's net income from continuing operations for the three months ended in Mar. 2024 was ¥52.8 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ¥235.8 Mil.

Hangzhou AGS Medtech Co Net Income From Continuing Operations Historical Data

The historical data trend for Hangzhou AGS Medtech Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou AGS Medtech Co Net Income From Continuing Operations Chart

Hangzhou AGS Medtech Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

54.74

45.23

104.80

144.96

217.24

Hangzhou AGS Medtech Co Quarterly Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial											34.23	44.58	64.37	74.06	52.78

Hangzhou AGS Medtech Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥235.8 Mil.

Hangzhou AGS Medtech Co (SHSE:688581) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hangzhou AGS Medtech Co Ltd (SHSE:688581) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6 Kangxin Road, Building 597, Building 5, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311106

Website

http://www.bioags.com

Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and providing patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.

Hangzhou AGS Medtech Co (SHSE:688581) Headlines

No Headlines